New DPI requirement specification reflects changing market

The acclaimed DPI specification, produced by Cambridge Consultants Ltd (CCL) to tackle the problem of poorly performing dry powder inhalers (DPIs) has been relaunched by the company to reflect changes in the market and regulation.

With the pipeline for the dry powder inhaler (DPI) market flooded with poorly designed products, CCL, a leading European technology design and development company, has issued a free generic requirements specification to help companies avoid the pitfalls into which so many fall.

According to CCL, too many companies fail to produce the dry powder inhaler they set out to create simply because they don't follow some essential and guiding principles. The result is that many designs either never reach the market, or fail to gain regulatory approval without the need for substantial redesign. This failure leads to development projects running behind schedule and significantly over budget.

Jon Tuckwell, who leads CCL drug delivery said, "The response to our last DPI requirement specification was very positive with a number of drug delivery companies having engaged in our methodology. However, since we first issued the specification last year, the market has seen several changes including the latest guidance from the FDA regarding dose counting. We have also further improved the specification by taking into consideration additional factors such as the anti-choking standards."

To request the free specifications please click here

Notes for editors:

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology critical issues for clients worldwide. For over 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of over 300 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, transport, energy, cleantech and wireless communications.

Created by three Cambridge graduates in 1960, the company has grown into a leading technology business, renowned worldwide for its ability to solve technical problems and provide innovative, practical solutions to commercial issues. In 2009, the company was awarded the prestigious Queen’s Award for Enterprise in International Trade, and in 2011 was awarded a second Queen's Award, this time for Innovation. For more information visit: www.CambridgeConsultants.com

Cambridge Consultants is part of Altran, global leader in innovation and high-tech engineering consulting. Altran supports companies in the creation and development of their new products and services. For thirty years, the Group has been providing services to key players in the fields of Aerospace, Automotive, Energy, Railways, Finance, Healthcare, and Telecoms. Present at every stage of project development from new-technology strategic planning through to manufacturing, Altran is able to capitalise on its expertise in four key domains: Product Lifecycle Management, Mechanical Engineering, Systems Engineering & Embedded Systems and IT Systems. With a global network of 17,000 collaborators (including 15,000 consultants) and 500 major clients throughout the world, the Group reported sales of €1,420m in 2011. More info: www.altran.com

For further information:

Cambridge Consultants

Patrick Pordage
Marketing Communications Director
Tel: +44 1223 420024
Patrick.Pordage@CambridgeConsultants.com